Notice: The portion of the term of this patent subsequent to Apr,18,2006 has been disclaimed.
及[63] Continuation-in-part of Ser.No.391,207, Aug,8,1989, abandomed.这两句如何理解呢?
这个专利还有其它两个相关专利,4822777和5032582。其中4822777这个专利的保护范围大于5194266。具体查询如下:
5,194,266
March 16, 1993
Amphotericin B/cholesterol sulfate composition and method
Inventors: Abra; Robert (San Francisco, CA), Guo; Luke S. S. (Lafeyette, CA)
Assignee: Liposome Technology, Inc. (Menlo Park, CA)
Notice: The portion of the term of this patent subsequent to April 18, 2006 has been disclaimed.
Appl. No.: 07/812,075
Filed: December 19, 1991
The present invention is a continuation-in-part of U.S. patent application for \"Amphotericin B/Cholesterol Sulfate Cholesterol Sulfate Composition and Method\", Ser. No. 07/391,207, filed Aug. 8, 1989, now abandoned.
4,822,777
April 18, 1989
Amphotericin B/cholesterol sulfate composition
Inventors: Abra; Robert (San Francisco, CA)
Assignee: Liposome Technology, Inc. (Menlo Park, CA)
Appl. No.: 07/019,575
Filed: February 27, 1987
5,032,582
July 16, 1991
Method for treating fungal infections with amphotericin B/cholesterol sulfate composition
Inventors: Abra; Robert (San Francisco, CA)
Assignee: Liposome Technology, Inc. (Menlo Park, CA)
Appl. No.: 07/320,354
Filed: March 8, 1989
This is a continuation of U.S. patent application entitled AMPHOTERICIN B/CHOLESTEROL SULFATE COMPOSITION AND METHOD, Ser. No. 019,575 filed Feb. 27, 1987 now U.S. Pat. No. 4,822,777.
其中4,822,777的保护范围大于5194266,notice这里是不是说多出来的保护内容到2006年4月18日结束啊? |